首页> 外文会议>Symposium on innovative polymers for controlled delivery >DRUG CARRIERS BASED ON CYCLODEXTRIN INCLUSION COMPLEXES FOR THE CONTROLLED RELEASE OF HYDROPHOBIC DRUGS
【24h】

DRUG CARRIERS BASED ON CYCLODEXTRIN INCLUSION COMPLEXES FOR THE CONTROLLED RELEASE OF HYDROPHOBIC DRUGS

机译:基于环糊精包合物的药物载体,用于疏水药物的控释

获取原文

摘要

A water-soluble β-CD derivative -carbonyl-β-CD was synthesized and characterized by Fourier transform infrared spectroscopy (FT-IR) and mass spectroscopy (MS). Drug release was studied by Ultraviolet-Vis (UV-Vis) spectroscopy using carbonyl-β-CD as drug carrier, water-insoluble benzoin as target drug, and water-soluble amantadine as competing agent. The formation of a benzoin-carbonyl-β-cyclodextrin inclusion complex greatly improved the solubility and bioavailability of benzoin. The target drug benzoin was released from the benzoin-carbonyl-β-cyclodextrin inclusion complex by adding the competing agent amantadine to the solution. The results showed that carbonyl-β-CD is an excellent drug carrier, and can be applied in controlled release of drugs.
机译:通过傅里叶变换红外光谱(FT-IR)和质谱(MS)合成水溶性β-CD衍生物 - 羰基-β-CD的羰基-β-CD。使用羰基-β-CD作为药物载体,水不溶性苯并作为靶药物,水溶性苯并氨基作为竞争剂,通过紫外-Vis(UV-Vis)光谱进行药物释放。苯并素 - 羰基 - β-环糊精包合物的形成大大提高了苯并素的溶解度和生物利用度。通过将竞争剂氨基氨基加入溶液,从苯并素 - 羰基-β-环糊精包合物中释放靶药物苯并素。结果表明,羰基-β-CD是优异的药物载体,可用于药物的控制释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号